European Organisation For Research & Treatment Of Cancer
Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma
- Conditions
- Astrocytoma, Grade IIIGlioblastoma
- Interventions
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2022-05-31
- Target Recruit Count
- 71
- Registration Number
- NCT03224104
- Locations
- 🇨🇭
UniversitaetsSpital Zurich, Zürich, Switzerland
🇦🇹Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH uniklinieken, Vienna, Austria
🇫🇷Assistance Publique - Hopitaux de Marseille - Hôpital de La Timone, Marseille, France
Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2023-02-21
- Target Recruit Count
- 55
- Registration Number
- NCT03134118
- Locations
- 🇳🇱
Academisch Ziekenhuis Maastricht, Maastricht, Netherlands
🇳🇱Erasmus MC, Rotterdam, Netherlands
🇧🇪Universitair Ziekenhuis Antwerpen (UZA), Edegem, Belgium
Synergism of Immunomodulation and Tumor Ablation
- Conditions
- Colorectal CancerLiver Metastases
- Interventions
- Radiation: Sterotactic body radiation therapy (SBRT)Other: Radiofrequency ablation (RFA)
- First Posted Date
- 2017-04-05
- Last Posted Date
- 2022-05-31
- Target Recruit Count
- 22
- Registration Number
- NCT03101475
- Locations
- 🇳🇱
Radboud University Medical Center Nijmegen, Nijmegen, Netherlands
🇨🇭Inselspital, Bern, Switzerland
🇫🇷Institut Bergonie, Bordeaux, France
Biomarker-based Study in R/M SCCHN
- Conditions
- Carcinoma, Squamous Cell of Head and Neck
- Interventions
- First Posted Date
- 2017-03-23
- Last Posted Date
- 2023-11-03
- Target Recruit Count
- 340
- Registration Number
- NCT03088059
- Locations
- 🇧🇪
CHU Saint-Pierre-Site Porte de Hal, Brussels, Belgium
🇮🇹IRCCS - Fondazione G. Pascale, Napoli, Italy
🇬🇧Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford, United Kingdom
Lenvatinib in Second Line Endometrial Carcinoma
- Locations
- 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
- Conditions
- Oropharyngeal CancerSupraglottic Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
- Interventions
- Procedure: Trans Oral Surgery (TOS)Radiation: Intensity-Modulated Radiation Therapy (IMRT)
- First Posted Date
- 2016-12-06
- Last Posted Date
- 2025-05-02
- Target Recruit Count
- 112
- Registration Number
- NCT02984410
- Locations
- 🇩🇪
Staedtisches Klinikum Leipzig - Klinikum St Georg, Leipzig, Germany
🇩🇪Universitaetsklinikum Leipzig, Leipzig, Germany
🇮🇹Istituto Clinico Humanitas, Milan, Italy
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2024-04-05
- Target Recruit Count
- 61
- Registration Number
- NCT02972060
- Locations
- 🇧🇪
Hopitaux Universitaires Bordet-Erasme - Hopital Universitaire Erasme, Brussels, Belgium
🇪🇸Hospital Universitario Virgen De La Victoria, Malaga, Spain
🇫🇷Gustave Roussy, Villejuif, France
Trabectedin Maintenance Post 1st-line in STS
- First Posted Date
- 2016-10-11
- Last Posted Date
- 2020-09-02
- Target Recruit Count
- 13
- Registration Number
- NCT02929394
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
🇫🇷Centre Leon Berard, Lyon, France
🇫🇷Institut Bergonie, Bordeaux, France
Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma
- Conditions
- Malignant Pleural Mesothelioma
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-08-11
- Last Posted Date
- 2024-04-05
- Target Recruit Count
- 37
- Registration Number
- NCT02863055
- Locations
- 🇧🇪
UZ Antwerpen, Antwerpen, Belgium
🇧🇪UZ Gent, Gent, Belgium
🇮🇹Ospedale San Paolo, Milan, Italy
Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)
- Conditions
- Metastatic DiseaseEsophagogastric AdenocarcinomaNo Previous Chemotherapy for Metastatic Esophagogastric Cancer
- Interventions